Evogene
Biotechnology company developing novel products for life science markets through the use of a unique CPB platform.
Launch date
Employees
Market cap
€14.1m
Enterprise valuation
€5m (Public information from Sep 2024)
Share price
$2.69 EVGN
Company register number 512838723
Rehovot Center District (HQ)
- hard tech
- biotechnology
- horizon europe
- sustainable development goals
- climate tech
- biotech and pharma
- core ai
- ai applications
- dietary supplements
- superfood
- predictive analytics
- genetics
- genome engineering
- drug development
- techbio
- ai drug discovery
- digital pharma
- organic
- techbio drug discovery
- biofuel
- crop protection
- crop
- gmo
- biopesticides
Authorizing premium user...